National Institutes of Health: HIV Infections trials

The registry lists 831 HIV Infections studies with National Institutes of Health as lead sponsor. 9 are open to participants now and 114 have results posted.

Phase 1 352Phase 2 202Phase 3 66Phase 4 11No phase 245(a study in two phases counts in both)

Studies

Page 4 of 9. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GW873140 to Treat HIV-1 Infected AdultsCompletedNCT00076284Phase 2
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV VaccinesCompletedNCT00076063Phase 1/2
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEPCompletedNCT00076037Phase 1
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected AdolescentsCompletedNCT00075907Phase 3
• A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide TrialsCompletedNCT00075062
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
• Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIVCompletedNCT00074399Phase 3
• Immune Function of Infants With HIVCompletedNCT00073229
• Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected AdultsCompletedNCT00073216Phase 1
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected AdultsCompletedNCT00071851Phase 1/2
• An Electronic Pillbox for People With HIVStatus unknownNCT00071500Phase 1
• Growth Hormone to Increase Immune Function in People With HIVCompletedNCT00071240Phase 2
• Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIVCompletedNCT00070980Not applicable
• Immune Response to Influenza Vaccine in HIV-Infected IndividualsCompletedNCT00069914
• Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected PatientsCompletedNCT00069498Phase 1
• Resistance to HIV InfectionStatus unknownNCT00069485
• Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected AdultsCompletedNCT00069030Phase 1
• HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, ChinaWithdrawnNCT00068991Phase 1
• Analysis of Immune Responses to HIV VaccinesCompletedNCT00068978
• Evaluating Immune Function Tests in People With HIVCompletedNCT00067795
• Preventing Unplanned Pregnancies in HIV Infected Zambian CouplesStatus unknownNCT00067522Not applicable
• Antiviral Therapy and HIV in the Female Genital TractCompletedNCT00067106
• HIV Symptom Management Program for African American MothersCompletedNCT00065819Phase 3
• Dehydroepiandrosterone Effects on HIV-1 ReplicationCompletedNCT00065104Phase 2
• Relaxation Response With Acupuncture for HIV PatientsCompletedNCT00064740Phase 2
• Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected MenCompletedNCT00063804Phase 1
• Education Program to Promote Female Condom UseStatus unknownNCT00062634Not applicable
• Safety of an Oral HIV Vaccine in HIV Uninfected VolunteersStatus unknownNCT00062530Phase 1
• Daily Nevirapine to Prevent Mother to Infant Transmission of HIVCompletedNCT00061321Phase 3
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected PatientsCompletedNCT00061256Phase 2
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected AdultsStatus unknownNCT00061243Phase 1
• Alternative Dosing Strategy for Anti-HIV DrugsCompletedNCT00059384Phase 4
• Male Circumcision and HIV Rates in KenyaCompletedNCT00059371Phase 3
• Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected PatientsCompletedNCT00058734Phase 1
• Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIVCompletedNCT00057538Phase 2
• Tuberculosis in HIV Infected Patients in UgandaCompletedNCT00057421Phase 2
• Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIVCompletedNCT00056797Phase 2
• HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV DrugsCompletedNCT00056758Phase 1
• Determining an Effective Site (Groin Versus Arm) for Giving HIV VaccinesCompletedNCT00056745Phase 1
• Treatment of Acute HIV Infection to Preserve Immune FunctionCompletedNCT00055094
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected AdultsCompletedNCT00054860Phase 1
• Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United StatesCompletedNCT00054743Phase 4
• Handheld Computers to Improve Adherence to Anti-HIV Drug RegimensCompletedNCT00053443Phase 2
• Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected PeopleCompletedNCT00053430Phase 2
• Immunologic Control of Drug Resistant HIVStatus unknownNCT00053404
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected PatientsCompletedNCT00052182Phase 1
• Development of a New HIV VaccineCompletedNCT00051922Phase 1
• Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive AdultsCompletedNCT00051831Not applicable
• Promoting Adherence to Anti-HIV Drug RegimensCompletedNCT00051805Not applicable
• Computer-Assisted Adherence Program for Patients Taking Anti-HIV DrugsTerminatedNCT00051766Not applicable
• Screening HIV-Infected Patients for Vaccine StudiesCompletedNCT00051519
• Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy AdultsCompletedNCT00051454Phase 1/2
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable
• Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
• Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV DrugsCompletedNCT00050921Not applicable
• Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV DrugsCompletedNCT00050908
• Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2CompletedNCT00050726Phase 2
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV InfectionCompletedNCT00050284
• Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy VolunteersCompletedNCT00050180Phase 4
• Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV DrugsCompletedNCT00050063
• HIV Prevention Preparedness StudyCompletedNCT00048282
• Rapid HIV Tests for Women Late in Pregnancy and During LaborTerminatedNCT00046436
• Multicenter AIDS Cohort Study (MACS)Status unknownNCT00046280
• Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug ResistanceCompletedNCT00046033Phase 2
• Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal WomenTerminatedNCT00044837Phase 1
• HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)CompletedNCT00043641
• Safety of an HIV DNA Vaccine Given to HIV Uninfected AdultsCompletedNCT00043511Phase 1
• A Study of HIV Levels During Pregnancy and After ChildbirthCompletedNCT00041964
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease InhibitorCompletedNCT00041769Phase 3
• Endothelial Dysfunction as a Risk Factor in HIV StudyCompletedNCT00039663Phase 1
• A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk ContactsCompletedNCT00038688Phase 3
• Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected InfantsCompletedNCT00038480Phase 1
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV InfectionCompletedNCT00038272Phase 2
• Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug TherapyCompletedNCT00038259Not applicable
• A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV DrugsWithdrawnNCT00037063Not applicable
• Effects of Changing HIV Therapy at Lower Versus Higher Viral LoadsCompletedNCT00036465Phase 2
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct ObservationCompletedNCT00036452Phase 2
• Study of Anti-HIV Therapy IntensificationCompletedNCT00034086Not applicable
• Treatment of Depression With Massage in HIVCompletedNCT00033852Phase 2
• Immune Restoration by Lipoic Acid in AIDSCompletedNCT00033176Phase 2
• The Use of Reiki for Patients With Advanced AIDSCompletedNCT00032721Phase 2
• Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected ChildrenCompletedNCT00032669Phase 1
• Screening Protocol for HIV Vaccine StudiesCompletedNCT00031304
• The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in MonkeysCompletedNCT00031109Not applicable
• Increasing HAART-Induced Immune Restoration With CyclosporineCompletedNCT00031070Phase 2
• Adding New Drugs for HIV Infected Patients Failing Current TherapyCompletedNCT00031044Phase 1/2
• A Study to Prepare for Future HIV Vaccine StudiesCompletedNCT00029744
• A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the BodyCompletedNCT00029341Phase 2
• Alternative Stress Management Approaches in HIV DiseaseCompletedNCT00029237Phase 3
• Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected PeopleCompletedNCT00028366Not applicable
• Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive CareCompletedNCT00028327Phase 3
• Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA GelCompletedNCT00028132Phase 1
• Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected VolunteersCompletedNCT00027482
• An Investigational Combination Vaccine Given to People Who Are Not Infected With HIVCompletedNCT00027365Phase 1
• A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)CompletedNCT00027352
• Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIVCompletedNCT00027339Phase 2
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected AdultsCompletedNCT00027261Phase 1
• Use of a Test That Evaluates How the Body Handles Insulin and GlucoseCompletedNCT00027092
• Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young AdulthoodCompletedNCT00026806